AstraZeneca, which sells its vaccine in India under the brand name Covishield, has admitted that its vaccine may, in rare cases, lead to side effects including blood clots. The UK-based pharmaceutical firm AstraZeneca made the revelation in court documents, reported The Telegraph. It said its Covid-19 vaccine, in rare cases, led to Thrombocytopenia syndrome (TTS).